Cosmetic Compliance
Intelligence & Solutions
Home / News / Details

China Provincial MPA Fines Two Notifiers for Failing to Upload Cosmetic Efficacy Evaluation Summary

Two general cosmetic enterprises were warned and fined 10,000 yuan respectively for failing to upload the cosmetic efficacy evaluation summary. The supervision and inspection on enterprises' implementation status of the new regulation have begun.

 

Background

In Cosmetic Supervision and Administration Regulation (CSAR), National Medical Products Administration (NMPA) specifies that cosmetic's efficacy claims shall be supported by sufficient scientific basis, and requires enterprises to publicize the   summary of cosmetic efficacy evaluation. Later on Apr. 9, 2021, NMPA issued the finalized Standards for Cosmetic Efficacy Claim Evaluation, rolling out a detailed plan to standardize and guide the evaluation of cosmetic efficacy claims.

On Jul. 6, 2022, China Tianjin Medical Products Administration (MPA) released two administrative penalties. 1,2 Two general cosmetic enterprises were warned and fined 10,000 yuan respectively for failing to upload the cosmetic efficacy evaluation summary to the general cosmetic notification information management system. It is worth noting that one of the enterprises has actually done the efficacy evaluation, and can provide the evaluation summary during the on-site inspection, but it was still punished. It can be seen that as long as the evaluation summary is not uploaded in time, the enterprise will face penalties.

This is the first batch of penalty cases for failing to upload evaluation summary after NMPA required enterprises to evaluate the cosmetic efficacy, which is quite a warning to the industry.

Enterprise

Product

Notification Date

Illegal Activity

Punishment Basis

Punishment

Enterprise A

Essence that claims moisturizing efficacy

Jul. 16, 2021

The efficacy evaluation has been carried out, but the evaluation summary has not been uploaded to the general cosmetic   notification information management system before May 1, 2022.

  • Article 22 of CSAR

Efficacy claims of cosmetics shall be supported by sufficient scientific basis. Cosmetics registrants and notifiers shall publicize the summary of the literature document, research data, and/or product efficacy evaluation document which serves as the basis of the efficacy claims on the special website prescribed by the NMPA, and accept public supervision.

  • Article 62 of CSAR

If any of the following circumstances occurs, the medical products administration departments shall order enterprises to make corrections and give a warning as well as a fine of more than 10,000 yuan and less than 30,000 yuan. In serious circumstances, the enterprises shall be ordered to suspend the production and/or operation. A fine of more than 30,000 yuan and less than 50,000 yuan shall be imposed. The legal representative or the main responsible person, the person who is directly in charge and other directly responsible persons of the illegal unit shall be fined more than 10,000 yuan and less than 30,000 yuan:

(I) Failure to publish the summary of the basis for cosmetic efficacy claims as prescribed;

(Omit circumstances II, III, IV, V)

The two enterprises were warned and fined 10,000 yuan.

Lyophilized tablets that claims moisturizing efficacy

Apr. 22, 2022

The efficacy evaluation has been carried out, but the efficacy evaluation summary has not been uploaded at the time of product notification.

Enterprise B

Essence that claims moisturizing efficacy

Jan. 5, 2022

The efficacy evaluation has not been carried out, and the efficacy evaluation summary has not been uploaded at the time of product notification.

Notes:

  • Due to the regional recurrence of COVID-19 in China in early 2022, Shanghai, Guangdong, Beijing, Jiangsu, Chongqing and Zhejiang MPA issued announcements stating that for cosmetics registered or notified from May 1, 2021 to Dec. 31, 2021, the uploading of efficacy evaluation summary, and supplementary of notification documents can be extended to Dec. 31, 2022. However, Tianjin has not postponed it, and the deadline is still May 1, 2022;

  • Up to now, the efficacy evaluation summaries of these three products have been supplemented. The evaluation methods adopted are literature document investigation and laboratory test.

Under the new cosmetic regulations, as long as enterprises complete the submission of notification documents, their general cosmetic products are considered as “notified” and then can be manufactured and/or imported. However, product “notified” does not equal to product “compliance." NMPA and local MPA mainly adopt post-notification supervision as well as post-market supervision and inspection to supervise the notified products. Enterprises may face severe penalties if the notification documents or notified products do not comply with the new regulations.

The two administrative penalties may signal that regulators have begun to inspect the implementation status of the new regulations in the enterprises. 3 It is recommended to pay close attention to the effective time of the new regulations and the expiration time of transitional periods, and prepare notification documents in strict accordance with the new regulations.

ChemLinked can assist enterprises in cosmetic efficacy evaluation and preparing evaluation report and summary. If you have any further cosmetic compliance consultation, please feel free to contact us at cosmetic@chemlinked.com.

BANNER 810 150  gif.gifFurther Reading

We provide full-scale Chinese cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by cosmetic@chemlinked.com
Copyright: unless otherwise stated all contents of this website are ©2022 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com